Inovio Biomedical Financial Market Data
| Last Close 22-Aug-2008 |
$1.06 |
Price/ Sales Ratio |
9.08 |
| 52-Week High |
$2.09 |
Price/ Book Ratio |
1.97 |
| 52-Week Low |
$0.50 |
Price/ Earnings Ratio |
-- |
| 60-Month Beta |
(0.5) |
Price/ Cash Flow Ratio |
-- |
| Market Cap (mil.) |
$46.5 |
Return on Assets |
(25.3%) |
| Shares Outstanding (mil.) |
43.9 |
Return on Equity |
(32.6%) |
| Dividend Rate |
-- |
Current Ratio |
2.60 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
-- |
| # of Institutional Holders |
20 |
% Owned by Institutions |
12.0% |
| Latest Short Interest Ratio |
0.72 |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
64.9% |
4.3% |
3,020.4% |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |

This data is provided as per license from EDGAR Online